Himalaya Reosto

Himalaya Reosto is a proprietary Ayurvedic blend crafted to support skeletal integrity and combat bone degeneration. Designed to enhance bone mineral density, it serves as a botanical alternative to conventional osteoporosis therapies.

Rooted in centuries-old Ayurvedic principles, Reosto integrates time-tested herbs with contemporary research to deliver a formulation that aligns ancient healing with modern needs. Its relevance extends to clinical settings where long-term skeletal maintenance is crucial.

Reosto is especially beneficial for:

• Postmenopausal women experiencing hormonal bone loss
• Elderly individuals with age-related skeletal weakening
• Patients diagnosed with osteopenia or osteoporosis seeking plant-based alternatives

• Arjuna (Terminalia arjuna): Renowned for enhancing bone strength and cardiovascular support
• Guggulu (Commiphora mukul): A potent anti-inflammatory resin that aids joint comfort
• Ashvagandha (Withania somnifera): Offers anabolic effects, reducing cortisol levels and supporting musculoskeletal resilience
• Godanti Bhasma: A bioavailable calcium source derived from gypsum, promoting bone mineralization

These botanicals work synergistically to improve bone turnover, mitigate bone loss, and enhance the structural integrity of skeletal tissue.

Reosto stimulates new bone formation by accelerating mineral deposition and enhancing the structural matrix.

It suppresses osteoclast activity, thereby reducing the rate of bone degradation and maintaining bone density.

By promoting osteoblast function, Reosto supports the synthesis of bone proteins and matrix, crucial for long-term skeletal health.

The adaptogenic properties of Ashvagandha and Guggulu help regulate endocrine factors, including cortisol and estrogen, which directly influence bone health.

• Management of postmenopausal and senile osteoporosis
• Treatment of osteopenia and low bone mineral density (BMD)

• Accelerated healing of bone fractures
• Degenerative changes in osteoarthritis and rheumatoid arthritis

• Prevention of corticosteroid-induced bone loss
• Bone maintenance during prolonged immobilization or sedentary lifestyle
• Hormonal transition support during perimenopause

• Reosto tablet dosage: 1-2 tablets twice daily, or as directed by a healthcare provider
• Duration: Often prescribed as a long-term therapy, ranging from 3 to 12 months
• Administration Timing: Preferably post-meals for optimal absorption
• Combination Therapy: Can be co-administered with calcium and vitamin D3 under supervision

• Gastrointestinal disturbances including bloating and discomfort
• Transient metallic taste or mild nausea

• Allergic reactions such as rash or urticaria
• Elevated serum calcium levels in sensitive individuals

• Documented allergy to any of the herbal ingredients
• Severe hyperparathyroidism, sarcoidosis, or related calcium metabolism disorders
• History of nephrolithiasis or hypercalcemia

Avoid concurrent use of synthetic calcium without healthcare guidance to prevent hypercalcemia or calcinosis.

• May interact with antiresorptive agents like bisphosphonates or SERMs
• Potential amplification of effects when used with diuretics or corticosteroids
• Caution advised when combined with other herbal supplements targeting bone or hormonal health

• Long-term use should be monitored for calcium balance and bone marker levels
• Adjust dosage in patients with hepatic or renal impairment
• Use with caution in individuals with chronic gastritis, ulcers, or malabsorption syndromes

Elderly individuals often present with reduced metabolic clearance and altered drug absorption, necessitating dosage adjustments when using Himalaya Reosto. A lower initiation dose is generally advised, with gradual titration based on clinical response and tolerance. Regular monitoring is essential to assess bone mineral density improvements and detect any potential side effects. Additionally, given the increased risk of falls in this demographic, supportive measures such as balance-enhancing therapy and concurrent calcium management should be considered.

Due to insufficient clinical evidence regarding fetal and neonatal safety, Himalaya Reosto is not recommended during pregnancy unless explicitly prescribed by a healthcare provider. Certain ingredients in the formulation may exert hormonal or uterotonic effects, which could pose risks during gestation. During lactation, caution is strongly advised. The potential for herbal constituents to alter hormonal profiles or pass into breast milk makes its use inadvisable in nursing mothers without medical supervision.

Himalaya Reosto is not formulated for use in children under the age of 18 unless specifically directed by a pediatric specialist. The absence of robust pediatric trials and long-term safety data precludes routine use in juvenile bone disorders. In rare cases where administration is considered, close supervision and periodic evaluations are mandatory to avoid unintended endocrine or skeletal effects.

An overdose of Himalaya Reosto, though uncommon, may manifest with nonspecific gastrointestinal symptoms such as:

• Nausea
• Vomiting
• Abdominal discomfort or cramping

In susceptible individuals, especially those with impaired calcium metabolism, signs of hypercalcemia may emerge, including:

• Fatigue and weakness
• Polyuria and dehydration
• Electrolyte imbalances

• Cease further intake immediately
• Seek urgent medical evaluation
• Initiate supportive care, including hydration and electrolyte correction

Hospital-based management may be necessary in cases of persistent symptoms or confirmed biochemical abnormalities.

Reosto tablets should be stored in a cool, dry environment with controlled room temperature, ideally between 15°C and 30°C. High humidity may degrade active herbal constituents and compromise product efficacy.

Direct sunlight and excessive moisture can alter the chemical stability of the herbal compounds. Always store the product in its original container away from bathroom shelves, windowsills, or other humid spaces.

Observe the expiration date printed on the product packaging. Discontinue use once the shelf life has elapsed, even if the product appears unchanged. Regularly rotating stock is essential in both retail and personal storage settings.

Avoid touching tablets with wet or unclean hands. Cross-contamination may compromise safety and introduce microbial risks, especially in multi-use containers.

The integrity of the blister pack or sealed bottle helps protect against environmental exposure. Do not transfer tablets to alternate containers unless directed by a pharmacist.

Patient education should include guidance on:

• Closing caps tightly after each use
• Keeping the product out of reach of children
• Not using damaged or discolored tablets

These measures preserve therapeutic potency and ensure safe administration throughout the course of therapy.

What is Himalaya Reosto used for?

Reosto Himalaya tablets can be beneficial for individuals with weak bones (osteoporosis) caused by factors like illness, aging, or the menopausal stage of life. It is also helpful in situations involving fractures and bone damage following procedures.

What is Reosto tablet used for?

Reosto Himalaya tablets can be beneficial for individuals with weak bones (osteoporosis) caused by factors like illness, aging, or the menopausal stage of life. It is also helpful in situations involving fractures and bone damage following procedures.